Latest News

Date Title Topic
17 Nov 2015 Distinct Evolutionary Trajectories Reported for Different Melanoma Subtypes Pathology/Molecular biology - Melanoma
16 Nov 2015 FDA Approves Osimertinib to Treat Patients With EGFR T790M Positive Advanced NSCLC After Progression to Other EGFR Tyrosine Kinase Inhibitors Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
12 Nov 2015 FDA Approves Cobimetinib as Part of Combination Treatment for Advanced Melanoma Melanoma - Anticancer agents & Biologic therapy
11 Nov 2015 Immunosurveillance in Breast Cancer Breast cancer - Cancer Immunology and Immunotherapy
10 Nov 2015 ESMO Preceptorship on Lung Cancer
10 Nov 2015 Pembrolizumab Receives FDA Breakthrough Therapy Designation in Advanced Colorectal Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
06 Nov 2015 European Medicines Agency’s Review Concludes Evidence Does Not Support That HPV Vaccines Cause Complex Regional Pain Syndrome and Postural Orthostatic Tachycardia Syndrome Epidemiology/Etiology/Cancer Prevention
05 Nov 2015 Patient-Derived Tumour Xenograft Models Encyclopedia Translational research
04 Nov 2015 FDA Approves Talimogene Laherparepvec for the Treatment of Melanoma Melanoma - Cancer Immunology and Immunotherapy
03 Nov 2015 FDA Approves Ipilimumab to Reduce the Risk of Melanoma Recurrence After Surgery Melanoma - Cancer Immunology and Immunotherapy
02 Nov 2015 EMA Recommends Approval of Ciambra, Pemetrexed Hospira and Pemetrexed Medac Lung and other thoracic tumours - Anticancer agents & Biologic therapy
30 Oct 2015 FDA Approves Liposomal Irinotecan for Advanced Pancreatic Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
29 Oct 2015 The International Consensus of Intrinsic Subtypes of Colorectal Cancer Genitourinary cancers - Translational research
28 Oct 2015 EMA Adopts a Positive Opinion Recommending Changes to the Terms of the Marketing Authorisation for Aprepitant Cancer in Special Situations - Palliative and supportive care
27 Oct 2015 FDA Approves Trabectedin for Certain Types of Advanced Soft Tissue Sarcoma Lung and other thoracic tumours - Anticancer agents & Biologic therapy